|
 Dr Theodore Torphy,
Chief Scientific Officer & Head External Research & Early Development,
Johnson & Johnson, United States
 Mr Murtaza Khorakiwala,
Managing Director,
Wockhardt, India
 Dr Tsutomu Une,
Chairman of the Board,
Ranbaxy Laboratories,
Member of the Board, Senior Executive Officer of Corporate Strategy, Daiichi Sankyo, Japan
 Dr M.K. Bhan,
Secretary, Ministry of Science & Technology, Department of Biotechnology,
Government of India, India
 Dr Rayasam (Ray) Prasad,
Chief Operating Officer - Global (Biologics),
Biological E. Limited, India
|
|
|
1 December 2009, Tuesday - Pre Conference Innovation Forum1 December 2009, Tuesday - Pre Conference Innovation Forum
08.00 Registration and refreshments09.00 Chairman's opening remarks
Director, Strategic Alliances & Business Development Centre for Cellular and Molecular Platforms (C-CAMP), National Centre for Biological Sciences (NCBS), India
09.10 Keynote: Driving drug innovation in India to bring it at the forefront of drug discovery in Asia and globally
- Market trends and drivers of India’s biopharmaceutical industry
- Looking into the emerging innovations from India and their impacts
- India’s biopharmaceutical industry: Evolving from generics to innovation drugs
Secretary, Ministry of Science & Technology, Department of Biotechnology, Government of India, India
09.40 Paving the way for India's innovations and enriching its biological research
- Establishing C-CAMP as a catalyst for bioscience research and development in India
- Supporting India’s biomedical industry to encourage innovation from academia and the industry
- Assessing C-CAMP’s impact in the industry and its long term objective
Director, Strategic Alliances & Business Development Centre for Cellular and Molecular Platforms (C-CAMP), National Centre for Biological Sciences (NCBS), India
Developing new and next generation vaccines from India10.40 Expression of HPV L1 protein in planta for the production of recombinant vaccine against cervical cancer
- Cost effective systems for large-scale production of proteins
- Expressing the HPVL1 gene in transgenic Nicotiana
- Signal peptides for targeting the protein
Scientist, Rajiv Gandhi Centre for Biotechnology, India
Stem cells and regenerative medicines: where is India heading?11.10 Therapeutic stem cells in India
- Multipotency of adult stem cells
- Their therapeutic potential
- Whoever would cure, must use adult stem cells
- Human Treatments
- Practical associated problems
Chief Executive Officer and Founder, Tran-Scell Biologics, India
13.30 Realising clinical potential of human embryonic stem cells
- Embryonic stem cell lines and research in India
- Lineage specific differentiation of Embryonic stem cells
- Efforts to conduct pre-clinical studies in non human primates
Dr Deepa Bhartiya, Scientist, National Institute of Research in Reproductive Health , India
14.00 Biological properties and therapeutic potential of embryonic and adult stem cells
- Differentiation bias of human ES cells
- Differentiation of umbilical cord derived mesenchymal stem cells (UCMSCs)
- Potential therapeutic applications of human ES cells and UCMSCs
Dr Anish Sen Majumdar, Vice President, Stem Cell Research , Reliance Life Sciences Pvt. Ltd, India
14.30 Modulating stem cell functions in vitro
- The concept : Creation of a suitable microenvironment might allow modulation of stem cell functions in vitro
- Demonstrating the "proof of principle" using Hematopoietic Stem Cells
- Possible advantages of Microenvironment Technology
Scientist F, Stem Cell Biology , National Center for Cell Sciences, India
15.00 Human Embryonic Stem Cell Therapy – a new era in medicine
- Presenting the technology highlights
- Clinical applications and results
- The future of human embryonic stem cell therapy
Founder and Director, Nutech Mediworld, India
Innovative gene therapy from India16.00 Targeted approach for cancer therapy
- Focusing on gene therapy
- Discussing ligand directed drug delivery
- Presenting the important findings and their implications
Senior Vice President R&D, Actis Biologics, India
16.30 Nano Highways: Trends in molecular diagnostics
- A glimpse into the ever improving molecular diagnostics
- Presenting case study: HLL Lifecare R&D
- Assessing the impact of molecular diagnostics in the healthcare industry
Senior Executive Director, Research and Development and Strategic Planning, HLL Lifecare Limited, India
17.00 Chairperson's closing remarks17.10 End of Innovation Forum |
|
|
|
special delegate pricing for India based biopharmaceuticals
If you are from an India based local pharma or biotech, contact us at +65 6322 2770 or email us at esther.chan@terrapinn.com with information on your company to be considered for special rates*.
*Terrapinn reserves the right to determine eligibility to special rates.
|
|
|
|
